|
AU2016102201A4
|
|
Guanethidine sulfate drug intermediates cycloheptanone synthesis method
|
|
AU2016102230A4
|
|
Catalin drug intermediates 1,2,4-trihydroxybenzene triacetate synthesis method
|
|
AU2016102232A4
|
|
Cis-4-(2-methyl-p-tert-amyl-phenylpropionyl)-2,6-dimethyl- morpholine synthesis method
|
|
AU2016102217A4
|
|
Flurazepam drug intermediates o-fluorotoluene synthesis method
|
|
AU2016102231A4
|
|
Carbenicillin drug intermediates phenyl malonic acid benzyl ester synthesis method
|
|
AU2016102219A4
|
|
Metoclopramide drug intermediates 4-chlorine-3-nitrobenzene methyl ether synthesis method
|
|
AU2016102200A4
|
|
Thiacloprid drug intermediates1, 1-diethoxy propane synthesis method
|
|
AU2016102198A4
|
|
Dicloxacillin sodium drug intermediates 2, 6-dichloro toluene synthesis method
|
|
AU2016102194A4
|
|
Plant growth regulator indole drug intermediates inter-chlorobenzaldehyde synthesis method
|
|
AU2016102203A4
|
|
Clofibrate drug intermediates p-chlorophenol synthesis method
|
|
AU2016102199A4
|
|
Bromine benzyl ammonium drug intermediates adjacent bromine toluene synthesis method
|
|
AU2016102233A4
|
|
Ampicillin drug intermediates D(I)-α-benzyloxy-carbonyl amino-α-phenyl acetic acid synthesis method
|
|
AU2016102206A4
|
|
Benzene fluorine salicylic acid drug intermediates m-difluorobenzene synthesis method
|
|
AU2016102210A4
|
|
Chlormezanone drug intermediates p-chlorotoluene synthesis method
|
|
AU2016102216A4
|
|
Furosemide drug intermediates 2, 4-dichlorotoluene synthesis method
|
|
AU2016102220A4
|
|
Oxyphenbutazone drug intermediates 4-hydroxyazobenzene synthesis method
|
|
AU2016102221A4
|
|
Chlorobenzene dichloroethane drug intermediates o-chlorobromobenzene synthesis method
|
|
AU2016102226A4
|
|
Methotrexate drug intermediates p-iodotoluene synthesis method
|
|
AU2016102195A4
|
|
Furan propylamine drug intermediates 2-furan acrylic acid synthesis method
|
|
AU2016102211A4
|
|
Ribavirin drug intermediates 1,2,4-triazole-3-carboxylic acid methyl ester synthesis method
|
